Prevention of venous thromboembolism in medical and surgical patients

Cleveland Clinic Journal of Medicine

Volumn 72, Issue SUPPL.1, 2004, Pages

  Kaboli, Peter J ^a,b   Brenner, Adam ^c   Dunn, Andrew S ^c  

^a Center for Research in the Implementation of Innovative Strategies in Practice   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

BANDAGE; CHEMOPROPHYLAXIS; HOSPITALIZATION; HUMAN; MOBILIZATION; REVIEW; RISK FACTOR; SURGERY; THROMBOEMBOLISM; VEIN THROMBOSIS;

ANTICOAGULANTS; ASPIRIN; BANDAGES; CHEMOPREVENTION; EARLY AMBULATION; HOSPITALIZATION; HUMANS; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84884568856     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.Suppl_1.S7     Document Type: Article

References (48)

1. Maynard G, Halasyamani L. Venous thromboembolism prophylaxis for hospitalized patients: an implementation guide and model for improvement (part 1). Hospitalist 2004; 8:34-36.
2. Hoenig H, Rubenstein LV, Sloane R, Horner R, Kahn K. What is the role of timing in the surgical and rehabilitative care of community- dwelling older persons with acute hip fracture? Arch Intern Med 1997; 157:513-520 [erratum in Arch Intern Med 1997; 157:1444].
3. Wilkins R, Mixter G, Stanton J, Litter J. Elastic stockings in the prevention of pulmonary embolism: a preliminary report. N Engl J Med 1952; 246: 360-364.
4. Best AJ, Williams S, Crozier A, et al. Graded compression stockings in elective orthopaedic surgery. An assessment of the in vivo performance of commercially available stockings in patients having hip and knee arthroplasty. J Bone Joint Surg Br 2000; 82:116-118.
5. Tarnay TJ, Rohr PR, Davidson AG, et al. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous thrombosis. Surgery 1980; 88:489-496.
6. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl):338S-400S.
7. Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 2002; 122:1933-1937.
8. Silbersack Y, Taute BM, Hein W, Podhaisky H. Prevention of deepvein thrombosis after total hip and knee replacement. Low-molecularweight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br 2004; 86:809-812.
9. Elliott CG, Dudney TM, Egger M, et al. Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma. J Trauma 1999; 47:25-32.
10. Warwick D, Harrison J, Glew D, et al. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am 1998; 80:1158-1166.
11. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355:1295-1302.
12. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318; 1162-1173.
13. Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994; 271:1780-1785.
14. Nurmohamed MT, Rosendaal FR, Buller HR, et al. Low-molecularweight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340:152-156.
15. Bergmann JF, Segrestaa JM, Caulin C. Prophylaxis against venous thromboembolism [letter]. BMJ 1992; 305:1156.
16. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332:1330-1335.
17. Strebel N, Prins M, Agnelli G, Buller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective surgery? Arch Intern Med 2002; 162:1451-1456.
18. Mesko JW, Brand RA, Iorio R, et al. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership. J Arthroplasty 2001;16: 679-688.
19. Brotman DJ, Jaffer AK, Hurbanek JG, Morra N. Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty. Thromb Haemost 2004; 92:1012-1017.
20. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162:1833-1840.
21. Bauer KA, Eriksson BI, Lassen MR, Turpie AG; Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345:1305-1310.
22. Exanta (ximelagatran) Tablets, NDA 21-686: FDA Advisory Committee Briefing Document. September 10, 2004. Available at: www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4069B1_01_AstraZeneca- Backgrounder.pdf.
23. Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002; 12: 19-24.
24. American Society of Regional Anesthesia and Pain Medicine. Regional Anesthesia in the Anticoagulated Patient-Defining the Risks, 2002. Available at: www.asra.com/items_of_interest/consensus_statements/.
25. Spain DA, Richardson JD, Polk HC Jr, et al. Venous thromboembolism in the high-risk trauma patient: do risks justify aggressive screening and prophylaxis? J Trauma 1997; 42: 463-467.
26. Offner PJ, Hawkes A, Madayag R, Seale F, Maines C. The role of temporary inferior vena cava filters in critically ill surgical patients. Arch Surg 2003; 138:591-594; discussion 594-595.
27. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346:975-980.
28. Losito R, Gattiker H, Bilodeau G, Verville N, Longpre B. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease. J Lab Clin Med 1981; 97:241-250.
29. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based casecontrol study. Arch Intern Med 2000; 160:809-815.
30. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162:1245-1248.
31. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341:793-800.
32. Belch JJ, Lowe GD, Ward AG, et al. Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981; 26:115-117.
33. Schuurman B, den Heijer M, Nijs AM. Thrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all patients make sense? Neth J Med 2000; 56:171-176.
34. Gardlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet 1996; 347: 1357-1361.
35. Dhote R, Pellicer-Coeuret M, Belouet-Moreau C, et al. Venous thromboembolism in medical inpatients: prophylaxis with lowweight heparin in a university hospital and prevalence of thromboembolic events. Clin Appl Thromb Hemost 2001; 7:16-20.
36. Kleber FX, Witt C, Vogel G, et al. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J 2003; 145:614-621.
37. Harenberg J. Risk assessment of venous thromboembolism in medical patients. Semin Hematol 2000; 37(3 Suppl 5):3-6.
38. Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM 2000; 93:359-364.
39. Kierkegaard A, Norgren L. Graduated compression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarction. Eur Heart J 1993; 14:1365-1368.
40. Halkin H, Goldberg J, Modan M, Modan B. Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med 1982; 96:561-565.
41. Dahan R, Houlbert D, Caulin C, et al. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial. Haemostasis 1986; 16:159-164.
42. Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebocontrolled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110:874-879.
43. Hillbom M, Erila T, Sotaniemi K, et al. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand 2002; 106:84-92.
44. McGarry LJ, Thompson D, Weinstein MC, Goldhaber SZ. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care 2004; 10:632-642.
45. Cohen AT, Gallus AS, Lassen MR, et al. Fondaparinux vs. placebo for the prevention of venous thromboembolism in acute medical patients [abstract]. J Thromb Haemost 2003; 1(Suppl 1):P2046.
46. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7.
47. Aujesky D, Guignard E, Pannatier A, Cornuz J. Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement. J Gen Intern Med 2002; 17:788-791.
48. Kleinbart J, Williams MV, Rask K. Prevention of venous thromboembolism (chapter 31). In: Making Health Care Safer: A Critical Analysis of Patient Safety Practices. AHRQ Publication 01-E058. Rockville, MD: Agency for Healthcare Research and Quality; July 20, 2001. Available at: www.ahrq.gov/clinic/ptsafety/.